Loading...
3183 logo

WIN-Partners Co., Ltd.TSE:3183 Stock Report

Market Cap JP¥35.4b
Share Price
n/a
1Y-4.2%
7D-0.5%
1D0.5%
Portfolio Value
View

WIN-Partners Co., Ltd.

TSE:3183 Stock Report

Market Cap: JP¥35.4b

WIN-Partners (3183) Stock Overview

Through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. More details

3183 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends6/6

Rewards

Risk Analysis

No risks detected for 3183 from our risk checks.

3183 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW467,536 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
DA
davidlsander
467,536 investors already sharing narratives

WIN-Partners Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for WIN-Partners
Historical stock prices
Current Share PriceJP¥1,289.00
52 Week HighJP¥1,527.00
52 Week LowJP¥1,175.00
Beta0
1 Month Change-1.45%
3 Month Change4.97%
1 Year Change-4.23%
3 Year Change24.06%
5 Year Change29.16%
Change since IPO235.68%

Recent News & Updates

Recent updates

Analysis Article Feb 09

WIN-Partners (TSE:3183) Has Announced That It Will Be Increasing Its Dividend To ¥53.00

WIN-Partners Co., Ltd. ( TSE:3183 ) has announced that it will be increasing its dividend from last year's comparable...
Analysis Article Dec 16

WIN-Partners' (TSE:3183) Dividend Will Be Increased To ¥53.00

The board of WIN-Partners Co., Ltd. ( TSE:3183 ) has announced that it will be paying its dividend of ¥53.00 on the...
Analysis Article Nov 07

WIN-Partners' (TSE:3183) Shareholders Will Receive A Bigger Dividend Than Last Year

WIN-Partners Co., Ltd. ( TSE:3183 ) will increase its dividend from last year's comparable payment on the 30th of June...
Analysis Article Mar 14

WIN-Partners' (TSE:3183) Shareholders Will Receive A Bigger Dividend Than Last Year

WIN-Partners Co., Ltd. ( TSE:3183 ) has announced that it will be increasing its dividend from last year's comparable...
Analysis Article Feb 28

WIN-Partners (TSE:3183) Will Pay A Larger Dividend Than Last Year At ¥51.00

The board of WIN-Partners Co., Ltd. ( TSE:3183 ) has announced that it will be paying its dividend of ¥51.00 on the...
Analysis Article Nov 26

There May Be Reason For Hope In WIN-Partners' (TSE:3183) Disappointing Earnings

The market for WIN-Partners Co., Ltd.'s ( TSE:3183 ) shares didn't move much after it posted weak earnings recently. We...
Analysis Article Nov 08

WIN-Partners' (TSE:3183) Dividend Will Be Increased To ¥51.00

WIN-Partners Co., Ltd. ( TSE:3183 ) has announced that it will be increasing its dividend from last year's comparable...
Analysis Article May 22

We Think You Can Look Beyond WIN-Partners' (TSE:3183) Lackluster Earnings

The market for WIN-Partners Co., Ltd.'s ( TSE:3183 ) shares didn't move much after it posted weak earnings recently...

Shareholder Returns

3183JP HealthcareJP Market
7D-0.5%2.3%-2.7%
1Y-4.2%-1.6%30.5%

Return vs Industry: 3183 underperformed the JP Healthcare industry which returned -1.6% over the past year.

Return vs Market: 3183 underperformed the JP Market which returned 30.5% over the past year.

Price Volatility

Is 3183's price volatile compared to industry and market?
3183 volatility
3183 Average Weekly Movement2.4%
Healthcare Industry Average Movement3.5%
Market Average Movement4.0%
10% most volatile stocks in JP Market9.1%
10% least volatile stocks in JP Market2.1%

Stable Share Price: 3183 has not had significant price volatility in the past 3 months compared to the JP market.

Volatility Over Time: 3183's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1983653Hideumi Akizawawww.win-partners.co.jp

WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous coronary intervention products, including PTCA balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and embolic coils; and insulin pumps, as well as continuous glucose monitoring, and computed tomography equipment.

WIN-Partners Co., Ltd. Fundamentals Summary

How do WIN-Partners's earnings and revenue compare to its market cap?
3183 fundamental statistics
Market capJP¥35.44b
Earnings (TTM)JP¥2.04b
Revenue (TTM)JP¥92.28b
17.4x
P/E Ratio
0.4x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
3183 income statement (TTM)
RevenueJP¥92.28b
Cost of RevenueJP¥81.55b
Gross ProfitJP¥10.73b
Other ExpensesJP¥8.69b
EarningsJP¥2.04b

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)74.18
Gross Margin11.63%
Net Profit Margin2.21%
Debt/Equity Ratio0%

How did 3183 perform over the long term?

See historical performance and comparison

Dividends

4.3%
Current Dividend Yield
73%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/23 21:12
End of Day Share Price 2026/08/21 00:00
Earnings2026/06/30
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

WIN-Partners Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.